Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

FTC & Supreme Greens

This article was originally published in The Tan Sheet

Executive Summary

Direct Marketing Concepts, ITV Direct and Donald Barrett are barred from claiming that dietary supplement Supreme Greens with MSM treats, cures or prevents cancer, diabetes, arthritis and heart disease under a preliminary injunction obtained by the Federal Trade Commission announced July 2. The defendants also must prominently display disclaimers that infomercials aired to promote the product are paid advertisements, and may not sell or distribute products or services by means of a continuity program without informed consent from the consumer, according to the ruling. FTC filed charges in June 2004 alleging the defendants had deceptively marketed Supreme Greens through an infomercial, failed to disclose the program was a paid promotion and charged credit cards for automatic product shipments without consent...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS097015

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel